Market Overview:
The global Glucose-6-phosphate Dehydrogenase Gene Mutation Detection Kit market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of diabetes, rising awareness about early diagnosis and treatment of diabetes, and technological advancements in glucose-6-phosphate dehydrogenase gene mutation detection kits. Based on type, the global Glucose-6-phosphate Dehydrogenase Gene Mutation Detection Kit market can be segmented into early screening, diagnosis, and prognosis. The early screening segment is expected to grow at a higher CAGR than other segments during the forecast period owing to the increasing demand for preventive healthcare services. Based on application, the global Glucose-6-phosphate Dehydrogenase Gene Mutation Detection Kit market can be divided into hospital and clinic settings.
Product Definition:
The Glucose-6-phosphate Dehydrogenase Gene Mutation Detection Kit is a tool used to detect mutations in the G6PD gene. The kit is important because it can help identify individuals who are at risk for developing a condition called glucose-6-phosphate dehydrogenase deficiency (G6PDD), which can cause anemia.
Early Screening:
Early screening is the process of detecting genetic mutations in a very early stage. The major factor that propels the growth of this market includes increasing demand for early diagnosis and growing awareness about it. In addition, rising healthcare expenditure coupled with technological advancements also contributes to its growth. Moreover, increasing prevalence of diabetes and other chronic diseases due to lifestyle changes leads to market growth.
Diagnosis:
The global diagnosis and it's usage in glucose-6-phosphate dehydrogenase gene mutation detection kit market size was valued at USD 0.00 in 2016 and is expected to grow at a CAGR of XX% over the forecast period. The growing prevalence of diabetes due to aging, obesity, and an unhealthy lifestyle is one of the prime factors driving this market growth.
Application Insights:
The clinic application segment held the largest market share in 2017. This is due to the rising prevalence of diabetes and increasing awareness about early diagnosis of G-6-PD deficiency among patients with diabetes. The hospital application segment is expected to witness a lucrative CAGR during the forecast period owing to an increase in patient admissions for diabetic ketoacidosis (DKA). In addition, a rise in travel for medical purposes also contributes towards higher demand for glucose-6-phosphate dehydrogenase gene mutation detection kits at hospitals.
Diabetic ketoacidosis (DKA) is one of the most common reasons leading to hospital admission worldwide. It occurs when there are no enough insulin or cells that can convert sugar into insulin, thus causing hyperglycemia and dehydration among other complications such as brain injury and heart attack due to low potassium levels.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, increased healthcare expenditure, and availability of advanced treatment options for G6PD deficiency. Moreover, increasing incidence of diabetes in this region is further expected to drive growth during the forecast period. For instance, according to a study published by National Center for Health Statistics (NCHS), U.S., around 29 million people were diagnosed with diabetes in 2015 which was approximately 7% increase from 2010.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising prevalence of glucose-6-phosphate dehydrogenase deficiency and associated disorders such as hemolytic anemia.
Growth Factors:
- Increasing demand for early diagnosis of cancer
- Rising prevalence of chronic diseases
- Technological advancements in gene mutation detection kit market
- Growing awareness about benefits of early diagnosis and treatment of cancer
- Increasing funding for research and development in the field of gene mutation detection
Scope Of The Report
Report Attributes
Report Details
Report Title
Glucose-6-phosphate Dehydrogenase Gene Mutation Detection Kit Market Research Report
By Type
Early Screening, Diagnosis, Prognosis
By Application
Hospital, Clinic
By Companies
Daan, Sinochips, Zeesan, Hybribio, Ying Sheng Biology
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
143
Number of Tables & Figures
101
Customization Available
Yes, the report can be customized as per your need.
Global Glucose-6-phosphate Dehydrogenase Gene Mutation Detection Kit Market Report Segments:
The global Glucose-6-phosphate Dehydrogenase Gene Mutation Detection Kit market is segmented on the basis of:
Types
Early Screening, Diagnosis, Prognosis
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Daan
- Sinochips
- Zeesan
- Hybribio
- Ying Sheng Biology
Highlights of The Glucose-6-phosphate Dehydrogenase Gene Mutation Detection Kit Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Early Screening
- Diagnosis
- Prognosis
- By Application:
- Hospital
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Glucose-6-phosphate Dehydrogenase Gene Mutation Detection Kit Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The Glucose-6-phosphate Dehydrogenase Gene Mutation Detection Kit is a genetic testing kit that detects mutations in the glucose-6-phosphate dehydrogenase gene. The kit can be used to determine if a person has a mutation in the glucose-6-phosphate dehydrogenase gene, which may lead to an increased risk of developing diabetes.
Some of the major players in the glucose-6-phosphate dehydrogenase gene mutation detection kit market are Daan, Sinochips, Zeesan, Hybribio, Ying Sheng Biology.
The glucose-6-phosphate dehydrogenase gene mutation detection kit market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Glucose-6-phosphate Dehydrogenase Gene Mutation Detection Kit Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Glucose-6-phosphate Dehydrogenase Gene Mutation Detection Kit Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Glucose-6-phosphate Dehydrogenase Gene Mutation Detection Kit Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Glucose-6-phosphate Dehydrogenase Gene Mutation Detection Kit Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Glucose-6-phosphate Dehydrogenase Gene Mutation Detection Kit Market Size & Forecast, 2020-2028
4.5.1 Glucose-6-phosphate Dehydrogenase Gene Mutation Detection Kit Market Size and Y-o-Y Growth
4.5.2 Glucose-6-phosphate Dehydrogenase Gene Mutation Detection Kit Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Early Screening
5.2.2 Diagnosis
5.2.3 Prognosis
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Glucose-6-phosphate Dehydrogenase Gene Mutation Detection Kit Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Glucose-6-phosphate Dehydrogenase Gene Mutation Detection Kit Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Early Screening
9.6.2 Diagnosis
9.6.3 Prognosis
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Early Screening
10.6.2 Diagnosis
10.6.3 Prognosis
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Early Screening
11.6.2 Diagnosis
11.6.3 Prognosis
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Early Screening
12.6.2 Diagnosis
12.6.3 Prognosis
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Early Screening
13.6.2 Diagnosis
13.6.3 Prognosis
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Glucose-6-phosphate Dehydrogenase Gene Mutation Detection Kit Market: Competitive Dashboard
14.2 Global Glucose-6-phosphate Dehydrogenase Gene Mutation Detection Kit Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Daan
14.3.2 Sinochips
14.3.3 Zeesan
14.3.4 Hybribio
14.3.5 Ying Sheng Biology
